Evidence map›Paper›PMID 42681148›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Targeting, Mutagenesis, and Functional Testing Strategies for Large Collagens.

Xinyi Bao, Olivier Bornert, Alexander Nyström

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xinyi BaoFaculty of Biology, University of Freiburg, Freiburg, Germany.
Olivier BornertDepartment of Dermatology, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany.
Alexander NyströmDepartment of Dermatology, Faculty of Medicine, Medical Center - University of Freiburg, Freiburg, Germany. alexander.nystroem@uniklinik-freiburg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Collagens comprise a homogeneous family of cell-surface or extracellular proteins. Many of them are fundamental for health, and consequently, their deficiency or dysregulation occurs in a wide range of diseases, from tissue fragility to neoplastic and fibrosing diseases, to name a few. With the advent of new omics approaches, an increasing number of variants of specific collagens have been discovered in various conditions. Some of these variants lead to a loss of expression, highlighting the need to assess the functions and loss of specific collagens in such conditions, while other variants may involve changes in amino acids of unknown consequences. Thus, with the advent of newer omics technologies, there is an increasing need to engineer specific collagens and their encoding genes. However, for larger collagens, this can be challenging because of their size and repetitive structure. Using collagen VII as an example of a large collagen, we will describe strategies for protein engineering, functional analysis, and collagen gene targeting in cells that naturally express collagens.

Indexed as

CollagenCollagen Type VIIGene TargetingMutagenesisProtein EngineeringAnimalsCRISPR-Cas SystemsHumansCollagenCollagen Type VIICollagen VIICRISPR-Cas9DeletionDystrophic epidermolysis bullosaGibson assemblyPoint-mutationsRibonucleoprotein

Identifiers

PMID42681148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.